BBC News UK Edition
 You are in: Business  
News Front Page
N Ireland
Market Data
Your Money
Fact Files
Talking Point
Country Profiles
In Depth
BBC Sport
BBC Weather
Tuesday, 15 October, 2002, 16:05 GMT 17:05 UK
Ex-ImClone boss admits fraud
Disgraced ImClone founder Sam Waksal, centre. flanked by his lawyers, leaves Federal Court after pleading guilty.
Mr Waksal had hoped to reach a deal with prosecutors
The executive at the centre of the investigation into inside stock trading at biotech firm ImClone Systems has pleaded guilty to six of 13 charges against him.

ImClone Who's Who
Dr Samuel Waksal, former CEO
Martha Stewart, Waksal friend and lifestyle guru
Peter Bacanovic, Merrill Lynch broker
Douglas Faneuil, Merrill Lynch assistant
Dr Samuel Waksal, the firm's former chief executive, has in court pleaded guilty to two counts of securities fraud, one count of bank fraud, one count of perjury, one count of obstruction of justice and one count of conspiracy.

He faces up to 65 years in prison and millions of dollars in fines.

Mr Waksal is scheduled to be sentenced in January and remains free on bail.

Speaking before a New York court, a federal prosecutor said the government's investigation continues and may result in additional charges against Mr Waksal and others.

The official said the US Attorney's office has been developing evidence that Mr Waksal may have tipped off others, without elaborating who the others might be.

Broadening scandal

In speaking to reporters after his court appearance, Mr Waksal said the period since his arrest in June has been "a difficult and sad time" for him and his family and friends.

Former ImClone CEO Dr Samuel Waksal speaking before reporters after pleading guilty to charges of fraud.
Waksal: "I was wrong"

"I've made some terrible mistakes, and I deeply regret what has happened," Mr Waksal said.

"I was wrong."

The former boss at biotechnology firm ImClone Systems was indicted by a federal grand jury in August.

Mr Waksal stood accused of insider trading - tipping family members and others to sell ImClone shares the day before federal regulators refused to review its new cancer drug last December.

The scandal has broadened, with pressure growing on Martha Stewart, the US domestic products icon, and Mr Waksal's family members, who also sold shares ahead of a Food and Drug Administration (FDA) announcement late last year.

Stock sales

On 26 December, relatives sold $19m (12.9m) of ImClone stock, two days before the FDA announced it would not review Erbitux, ImClone's cancer-fighting drug.

Home lifestyle guru Martha Stewart
Martha Stewart sold shares just before they tumbled

The Securities and Exchange Commission (SEC) and the Department of Justice have alleged the decision to sell was based on knowledge passed from Mr Waksal to his family and at least two others.

Based on that information, Mr Waksal tried to sell nearly 80,000 shares of the company's stock but was blocked from doing so by two brokerage firms.

Among those who sold shares were Mr Waksal's daughter, Aliza, and other family members, including another daughter and her husband.

In addition, Ms Stewart unloaded all her shares two days before the FDA action, although she has denied acting on non-public information.

Prosecutors are continuing their investigation into Ms Stewart's actions, after a former Merrill Lynch sales assistant, Douglas Faneuil, pleaded guilty to a misdemeanour charge and agreed to co-operate over her case.

Ms Stewart has not been charged.

Politics of regulation

Worldcom goes bust

Enron fall-out

Andersen laid low

See also:

04 Oct 02 | Business
07 Aug 02 | Business
22 Aug 02 | Business
21 Aug 02 | Business
07 Aug 02 | Business
29 Jun 02 | From Our Own Correspondent
22 Jun 02 | Business
12 Jun 02 | Business
Internet links:

The BBC is not responsible for the content of external internet sites

Links to more Business stories are at the foot of the page.

E-mail this story to a friend

Links to more Business stories

© BBC ^^ Back to top

News Front Page | World | UK | England | N Ireland | Scotland | Wales |
Politics | Business | Entertainment | Science/Nature | Technology |
Health | Education | Talking Point | Country Profiles | In Depth |